- Datasheets:
- 0
- Resources:
- 0
- Image Analysis:
- 0
Our Catalogue of Reagents
CellAura catalogue products are generally available ex-stock and include new ligands for 2010.
To order products, please contact our trusted distributors who will manage your account.
To download Technical Datasheets for catalogue products, click 'add' for each product of interest. When your selection is complete, click 'Download selection'. You will then be able to download all the selected datasheets in a single zip-file download or as individual datasheets. If you would like technical details and guidance on using CellAura's fluorescent ligands, we have a range of Guides, Application Notes, Posters and Presentations available to download.
Current Catalogue
Pack sizes: 0.2, 0.5 and 1.0mg - add suffix '-020', '-050' or '-100' to the Catalogue number
Please contact us for quantities larger than our standard pack sizes.
| Product | Selectivity | Receptor: -logKD | | Cat. No | Add Datasheet |
|---|---|---|---|
| Adenosine family | |||
| Adenosine A3 antagonist [XAC] | A1: 6.57 | A2a: 6.74 | A3: 8.10 | CA200645 | |
| Adenosine agonist [NECA] | A1: 8.47 | A2a: 6.76 | A2b: 5.69 | A3: 8.57 | CA200623 | |
| Adenosine antagonist [XAC] | A1: 7.30 | A2a: 7.50 | A3: 7.37 | CA200634 | |
| Adrenoceptor family | |||
| β2 agonist [salbutamol] | β1: 6.73 | β2: 9.16 | CA200700 | |
| β2 antagonist [(S)-propranolol] | β1: 7.76 | β2: 9.21 | β3: 7.09 | CA200689 | |
| β2 antagonist [(±)-alprenolol] | β1: 7.50 | β2: 8.91 | β3: 7.09 | CA200719 | |
| β2 antagonist [(±)-pindolol] | β1: 7.01 | β2: 7.96 | β3: 6.42 | CA200733 | |
| β2 antagonist [(±)-propranolol] | β1: 7.25 | β2: 8.87 | β3: 6.98 | CA200656 | |
| β3 agonist [(S)-carazolol] | β1: 6.44 | β2: 8.76 | β3: 7.24 | CA201261 | |
| Dopamine family | |||
| D1 antagonist [SKF-83566] | D1: 7.02 | CA200767 | |
| GABA receptor family | |||
| GABA-B antagonist [CGP-54626A] | GABA-B: please enquire | CA200931 | |
| Histamine family | |||
| H1 antagonist [mepyramine] | H1: 8.07 | H2: 5.37 | H3: >6 | CA200799 | |
| H2 antagonist [aminopotentidine] | H1: >6 | H2: 8.94 | H3: 7.30 | CA200821 | |
| H3 antagonist [clobenpropit] | H1: 6.55 | H2: 5.71 | H3: 7.09 | CA200843 | |
| Muscarinic ACh family | |||
| M3 antagonist [pirenzepine] | M1: 6.24 | M3: 7.97 | M5: 6.29 | CA200887 | |
| Serotonin (5-HT) receptor family | |||
| 5-HT1A antagonist [NAN-190] | 5-HT1A: 8.75 | 5-HT1B: 5.57 | 5-HT2A: 6.34 | CA200992 | |
| 5-HT1B antagonist [ZM549865] | 5-HT1A: 5.76 | 5-HT1B: 6.7 | 5-HT2A: < 5.0 | 5-HT2B: < 5.0 | 5-HT2C: < 5.0 | CA201008 |
Are We Developing the Products You Want?
CellAura is developing a range of GPCR ligands to cover the most popular research and drug discovery targets. These items range from Product Concepts to Late State product candidates. They are not listed as general stock items, but are available on lead-times of approx 3 months.
Currently in Development
If you are interested in these development products, or wish to suggest others, please enquire.
| Product | Selectivity | Receptor: -logKD | | Cat. No | Add Datasheet |
|---|---|---|---|
| Adenosine family | |||
| Adenosine A2a antagonist | A2a, selectivity to be determined | tbc | |
| Adrenoceptor family | |||
| β2 antagonist [(S)-propranolol-green] | β1: | β2: | β3: | CA200693 | |
| Dopamine family | |||
| D2 antagonist [spiperone-green] | D1: | D2: | CA201581 | |
| D2 antagonist [spiperone-red] | D1: | D2: | CA201580 | |
| D3 antagonist | D3, selectivity to be determined | tbc | |
| D4 antagonist | D4: selectivity to be determined | tbc | |
| Histamine family | |||
| H4 antagonist | H4, selectivity to be determined | tbc | |
| Muscarinic ACh family | |||
| M1 antagonist | M1, selectivity to be determined | tbc | |
| M1-5 antagonist | M1-5 (non-selective) | tbc | |
| M2 antagonist | M2, selectivity to be determined | tbc | |
| Opiate receptor family | |||
| OPRL1 antagonist | OPRL1, selectivity to be determined | tbc | |
| Serotonin (5-HT) receptor family | |||
| 5-HT2A/B antagonist [4F4PP oxalate] | 5-HT1B: 6.7 | 5-HT2A: 9.2 | 5-HT2B: 9.8 | 5-HT2C: 5.7 | CA201019 | |
| 5-HT2A/C agonist | 5-HT2A, 2B, 2C, non-selective | tbc | |
| 5-HT2C antagonist | 5-HT2C, selectivity to be determined | tbc | |
| 5-HT4 antagonist | 5-HT4, selectivity to be determined | tbc |